PT110680A - REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY. - Google Patents

REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY.

Info

Publication number
PT110680A
PT110680A PT110680A PT11068018A PT110680A PT 110680 A PT110680 A PT 110680A PT 110680 A PT110680 A PT 110680A PT 11068018 A PT11068018 A PT 11068018A PT 110680 A PT110680 A PT 110680A
Authority
PT
Portugal
Prior art keywords
titration
research
forssman
reagent
antibody
Prior art date
Application number
PT110680A
Other languages
Portuguese (pt)
Inventor
Alberto Gaspar De Jesus Carlos
José Figueiredo Agostinho D'abreu Mendes Fernando
Dos Reis Galvão Sofia
Sofia Lopes Ferreira Ana
Original Assignee
Inst Politecnico De Coimbra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Politecnico De Coimbra filed Critical Inst Politecnico De Coimbra
Priority to PT110680A priority Critical patent/PT110680A/en
Publication of PT110680A publication Critical patent/PT110680A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A PRESENTE INVENÇÃO REFERE-SE A UM NOVO REAGENTE PRONTO A UTILIZAR CONSTITUÍDO POR GLÓBULOS VERMELHOS DE OVELHA QUE EXPRESSAM O ANTIGÉNIO FORSSMAN. ASSIM, ESTE PRODUTO PERMITE EFETUAR A PESQUISA E/OU TITULAÇÃO DO ANTICORPO ANTI-FORSSMAN DE UMA FORMA FÁCIL DE INTRODUZIR NA ROTINA LABORATORIAL, TAL COMO SE VERIFICA PARA COM OUTROS GRUPOS SANGUÍNEOS.THE PRESENT INVENTION REFERS TO A NEW REAGENT READY TO USE CONSTITUTED BY RED SHEEP BLOOD CELLS THAT EXPRESS THE FORSSMAN ANTIGEN. THEREFORE, THIS PRODUCT ALLOWS TO PERFORM THE RESEARCH AND / OR TITRATION OF THE ANTI-FORSSMAN ANTIBODY IN AN EASY WAY TO BE INTRODUCED IN THE LABORATORY ROUTINE, AS IS WITH OTHER BLOOD GROUPS.

PT110680A 2018-04-11 2018-04-11 REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY. PT110680A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PT110680A PT110680A (en) 2018-04-11 2018-04-11 REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT110680A PT110680A (en) 2018-04-11 2018-04-11 REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY.

Publications (1)

Publication Number Publication Date
PT110680A true PT110680A (en) 2019-10-11

Family

ID=69159451

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110680A PT110680A (en) 2018-04-11 2018-04-11 REAGENT FOR RESEARCH AND / OR TITRATION OF ANTI-FORSSMAN ANTIBODY.

Country Status (1)

Country Link
PT (1) PT110680A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1210819A (en) * 1966-11-08 1970-11-04 Organon Labor Ltd Immunochemical determinations of antigens and antibodies
CH500491A (en) * 1967-11-13 1970-12-15 Abbott Lab Process for obtaining a stable, sensitized preparation of erythrocytes
US3959456A (en) * 1971-02-02 1976-05-25 Beckman Instruments, Inc. Diagnostic slide test for infectious mononucleosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1210819A (en) * 1966-11-08 1970-11-04 Organon Labor Ltd Immunochemical determinations of antigens and antibodies
CH500491A (en) * 1967-11-13 1970-12-15 Abbott Lab Process for obtaining a stable, sensitized preparation of erythrocytes
US3959456A (en) * 1971-02-02 1976-05-25 Beckman Instruments, Inc. Diagnostic slide test for infectious mononucleosis

Similar Documents

Publication Publication Date Title
BR112018001042A2 (en) antibody constructs for flt3 and cd3
MX369149B (en) ANTIBODY CONSTRUCTIONS FOR CDH19 AND CD3.
AR113342A1 (en) CD47 / PD-L1 SPECIFIC ANTIBODIES
ECSP18023386A (en) STROMAL THYMIC LYMPHOPOYETIN (TSLP) BINDING MOLECULES AND METHODS OF USE OF THE MOLECULES
CO2018002446A2 (en) Thymic stromal lymphopoietin (tslp) binding molecules and methods of using the molecules
BR112018001531A2 (en) cd70 and cd3 antibody constructs
BR112018001374A2 (en) Bispecific antibody constructs that bind to egfrviii and cd3
CO2017005842A2 (en) Heterodimeric antibodies that bind to cd3 and cd38
CL2017000111A1 (en) Molecules with specificity for CD45 and CD79
BR112018067679A2 (en) cells expressing multiple chimeric antigen receptor (car) molecules and their use
BR112017018941A8 (en) CD20-BINDING MOLECULE, ITS USE, COMPOSITION AND METHOD IN VITRO TO DIRECTION COMPLEMENT-MEDIATED DEATH OF A CELL THAT EXPRESSES CD20
CO2017002719A2 (en) Anti-glucagon antibodies
AR110677A1 (en) ANTI-C1S ANTIBODIES AND METHODS TO USE THEM
CO6781491A2 (en) Cea antibodies
PE20151408A1 (en) CD47 ANTIBODIES THAT DO NOT EXHAUST PLATELETS OR RED BALLOONS AND METHODS OF USING THEM
BR112015023262B8 (en) Isolated antibody, immunoconjugate, pharmaceutical formulation and uses of antibody
AR101400A1 (en) INDIVIDUAL CHAIN INDIVIDUAL CHAIN ANTIBODY CONSTRUCTION WITH IMPROVED FABRIC DISTRIBUTION
AR101669A1 (en) ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
MX2016008250A (en) Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor.
BR112014008382A2 (en) antibody specifically binding the epitope on the c-met sema domain
MX2023010076A (en) Ilt7 binding molecules and methods of using the same.
CL2015001472A1 (en) Compositions and methods for epo directed antibodies.
AR093446A1 (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
MX2016016742A (en) CERAMIDES AND ITS USE IN THE DIAGNOSIS OF CARDIOVASCULAR DISEASE (CVD).
BR112018010669A2 (en) Anti-PCSK9 antibody and its application

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20180802